CVS Health news
The WiseView Research desk's stories that name CVS Health, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The CVS page →
- HeadlineCVS Q3 Preview: Accelerating Growth, Near 3% Yield, Meaningful Upside Long-Term
- HeadlineBrokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
- HeadlineCVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors
- HeadlineDid CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?
- HeadlineCVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS
- HeadlineShould You Buy CVS Health Stock While It's Under $100?
- HeadlineCVS Health Q3 Earnings Preview: How to Approach the Stock?
- HeadlineCVS Pharmacy expands fall assortment of collectibles, nostalgic favorites and seasonal exclusives
- HeadlineCVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
- HeadlineMinuteClinic® opens three new retail medical clinics to serve Massachusetts patients
- Headline3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are Shrinking
- HeadlineWhy CVS Health (CVS) is a Top Value Stock for the Long-Term
- HeadlineCVS Health (CVS) Exceeds Market Returns: Some Facts to Consider
- HeadlineCVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey
- HeadlineCVS to pay $315 million settlement to resolve DOJ opioid lawsuit
- HeadlineWall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?
- CongressRo Khanna sold $15,001 - $50,000 of CVS
- HeadlineCVS Stock Dips After Drop in Medicare Advantage Plan Ratings
- HeadlineCVS Health Trades at a Discount to Industry: How to Play the Stock?
- HeadlineHere's Why CVS Health (CVS) is a Strong Growth Stock
- HeadlineCVS Health (CVS) Advances While Market Declines: Some Information for Investors
- HeadlineCVS Pharmacy® celebrates opening of first pharmacy-focused location in Boston area
- HeadlineIs Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?
- HeadlineWhy CVS Is ‘Insanely Cheap,' ON Semi a Laggard Catching Up, and Grail Too Expensive to Chase
- HeadlineCVS Health® reminds New Yorkers that MMR vaccines are available statewide amid measles outbreak
- HeadlineCVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?
- HeadlineWill CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
- HeadlineLooking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
- HeadlineCVS Health to hold third quarter 2026 earnings conference call
- HeadlineCVS Health declares quarterly dividend
- HeadlineCVS Health (CVS) Falls More Steeply Than Broader Market: What Investors Need to Know
- CongressRo Khanna bought $1,001 - $15,000 of CVS
- CongressRo Khanna bought $1,001 - $15,000 of CVS
- CongressDwight Evans sold $1,001 - $15,000 of CVS
- CongressRo Khanna bought $1,001 - $15,000 of CVS
- CongressJohn Boozman bought $1,001 - $15,000 of CVS
- CongressMichael McCaul sold $15,001 - $50,000 of CVS
- CongressJulia Letlow sold $1,001 - $15,000 of CVS
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.